It's hardly an issue of political correctness, although Osterholm (UMn) wants to emphasize the risk to the MSM subgroup. That group's already aware of it. I'm much more worried that, by overemphasizing that aspect, others will decide there's no risk to the rest of the community and will avoid precautions.
It's hardly an issue of political correctness, although Osterholm (UMn) wants to emphasize the risk to the MSM subgroup. That group's already aware of it. I'm much more worried that, by overemphasizing that aspect, others will decide there's no risk to the rest of the community and will avoid precautions.
One consideration is the lack of vaccine doses. We're missing about 90% of the on-hand doses we need at this point. For the cases we know about. I suspect, thanks to a lack of testing, we have yet to understand the degree of community spread. Also, this virus isn't presenting in the same manner it has in the past. In the MSM community, (and speaking relative to the clinical evaluations) there's discussion that it's been seen and diagnosed for some time as one of the more common STDs. Often, only a single lesion has presented. A single lesion on a hand or arm might well go unnoticed and serve as a vector for more dissemination. Also, during the early onset of illness, "viral" symptoms predominate, and the virus can spread by air. At this time, the current thought is large-droplet transmission as we know fomite transmission is viable. The prolonged contact time I've seen so far is 3 hours (vs 15 min for COVID).
While we have not seen the spillover, it may have simply not been recognized. This was a discussion we had in my organization 2 weeks ago: How many would have recognized and had a high index of suspicion for MPV 3 months ago? The answer: None of us. But since we're all also engaged in public health work, our index of suspicion is now elevated. CDC and all the primary care organizations are trying to get more info out to increase awareness.
Sadly, Mr. Reines's comment seems to be an indication of how the right wing intends to weaponize this issue. Just as they have done with SARS-Cov-2 and attempted to do with Ebola. SS, DD.
It's hardly an issue of political correctness, although Osterholm (UMn) wants to emphasize the risk to the MSM subgroup. That group's already aware of it. I'm much more worried that, by overemphasizing that aspect, others will decide there's no risk to the rest of the community and will avoid precautions.
One consideration is the lack of vaccine doses. We're missing about 90% of the on-hand doses we need at this point. For the cases we know about. I suspect, thanks to a lack of testing, we have yet to understand the degree of community spread. Also, this virus isn't presenting in the same manner it has in the past. In the MSM community, (and speaking relative to the clinical evaluations) there's discussion that it's been seen and diagnosed for some time as one of the more common STDs. Often, only a single lesion has presented. A single lesion on a hand or arm might well go unnoticed and serve as a vector for more dissemination. Also, during the early onset of illness, "viral" symptoms predominate, and the virus can spread by air. At this time, the current thought is large-droplet transmission as we know fomite transmission is viable. The prolonged contact time I've seen so far is 3 hours (vs 15 min for COVID).
While we have not seen the spillover, it may have simply not been recognized. This was a discussion we had in my organization 2 weeks ago: How many would have recognized and had a high index of suspicion for MPV 3 months ago? The answer: None of us. But since we're all also engaged in public health work, our index of suspicion is now elevated. CDC and all the primary care organizations are trying to get more info out to increase awareness.
Sadly, Mr. Reines's comment seems to be an indication of how the right wing intends to weaponize this issue. Just as they have done with SARS-Cov-2 and attempted to do with Ebola. SS, DD.